HEIDELBERG PHARMA AG.
HPHA.XETRA | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Heidelberg Pharma AG is a Germany-based biopharmaceutical company focused on oncology. The company develops innovative therapeutics based on its proprietary Amanitin technology platform. Its primary focus is on Antibody-Drug Conjugates (ADCs), which deliver Amanitin payloads directly to cancer cells...Show More
Better Health for All
0
No evidence available to assess HEIDELBERG PHARMA AG on Better Health for All.
Fair Money & Economic Opportunity
0
Heidelberg Pharma AG is a biopharmaceutical company, not a financial institution. The provided articles focus on corporate governance, a declaration of conformity, and a code of conduct. They do not contain any information related to financial services, lending practices, customer financial data, or economic opportunity initiatives for underserved populations.
1
Therefore, no KPIs under the 'Fair Money & Economic Opportunity' value can be scored.
Fair Pay & Worker Respect
0
No specific, quantitative evidence was found across the provided articles for any of the KPIs under the 'Fair Pay & Worker Respect' value for Heidelberg Pharma AG (HPHA.XETRA). While some articles mentioned employee numbers
1
, staff costs
2
, or executive remuneration
3
, none provided the specific data points required by the rubric, such as living wage coverage
4
, median employee compensation
5
, collective bargaining share
6
, safety incident rates
7
, pay equity ratios
8
, worker engagement scores
9
, turnover rates
10
, labor violation incidents
11
, insecure contract share
12
, or health insurance coverage
13
. Information related to 'Heidelberger Druckmaschinen AG' or 'Heidelberg Materials' was explicitly excluded as it pertains to different entities.
Fair Trade & Ethical Sourcing
0
No specific, quantifiable evidence was found in the provided articles for Heidelberg Pharma AG regarding fair trade certifications, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in supplier contracts, materials risk index, or supplier diversity spend.
1
Information pertaining to 'Heidelberg Materials' or generic 'Heidelberg' was excluded as it refers to a different entity or is not explicitly attributed to Heidelberg Pharma AG.
Honest & Fair Business
-40
Heidelberg Pharma AG has a web-based whistleblower system, Integrity Line, hosted outside its network for reporting suspected legal violations, misconduct, or code of conduct deviations.
1
The company also has a Code of Conduct in place to guide employees' ethical and social behavior, covering aspects like conflict of interest and business dealings.
2
However, the company declares a deviation from recommendation A.5 of the German Corporate Governance Code (GCGC) regarding the appropriateness and effectiveness of internal control and risk management systems, stating that current reporting requirements do not fully meet the GCGC's expectations.
3
Additionally, the annual report and consolidated financial statements for both FY 2022 and FY 2023 were not published within the 90-day period recommended by the GCGC, though they were within the statutory period.
4
Kind to Animals
-40
Heidelberg Pharma is legally required to test drug candidates on animals before clinical testing in humans can be initiated, and states it meets all legal requirements relating to animal welfare.
1
The company used fewer than 1,000 animals in testing in 2025, a reduction from 1,000-1,500 animals in 2024. Heidelberg Pharma scientists have demonstrated the potential of computer-aided modeling (in silico) to optimize NAMPT inhibitors, indicating some exploration of alternative testing methods.
2
No War, No Weapons
0
No specific, concrete data points or factual information were found in the provided articles regarding Heidelberg Pharma AG's involvement in arms manufacturing, military contracts, dual-use technologies, peacebuilding initiatives, or any other metrics related to the 'No War, No Weapons' ethical value.
1
The articles primarily discuss corporate governance, a whistleblower system, a code of conduct, and financial reports. pertains to the University of Heidelberg, not Heidelberg Pharma AG.
2
Therefore, no KPIs can be scored based on the provided evidence.
Planet-Friendly Business
0
No specific, concrete data points for any of the Planet-Friendly Business KPIs were found for Heidelberg Pharma AG (HPHA.XETRA) in the provided articles.
1
pertains to 'Heidelberg Materials' and is not relevant to HPHA.XETRA. Articles and , which are for Heidelberg Pharma AG, explicitly state that no sustainability metrics, ESG targets, or data on scope 1-3 emissions, renewable energy, or water use are provided.
2
The company's internal control system does not explicitly consider sustainability-related objectives.
3
Respect for Cultures & Communities
0
The provided articles for HPHA.XETRA (Heidelberg Pharma AG) primarily focus on financial transactions, such as royalty financing agreements, and general company overviews related to its biopharmaceutical research and development. Articles that discuss community engagement or related policies (Articles and ) are explicitly about 'Heidelberg Materials,' a different entity, and therefore are not applicable to Heidelberg Pharma AG.
1
2
Consequently, there is no specific, concrete data available in the articles that directly addresses any of the KPIs related to 'Respect for Cultures & Communities' for HPHA.XETRA.
3
4
5
6
Safe & Smart Tech
0
No evidence available to assess HEIDELBERG PHARMA AG on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess HEIDELBERG PHARMA AG on Zero Waste & Sustainable Products.